BeOne Medicines: Redefining Cancer Care
Jan 12, 2026BeOne Medicines Co-Founder, Chairman and CEO John V. Oyler shares how the company is challenging the status quo in oncology, with a focus on affordability and access to benefit patients everywhere.
